7VG Stock Overview

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally. More details

7VG fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	4/6
Past Performance	5/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 16.4% below our estimate of its fair value

Earnings are forecast to grow 16.29% per year

Earnings grew by 47.5% over the past year

Analysts in good agreement that stock price will rise by 29.3%

Risk Analysis

High level of non-cash earnings

Shares are highly illiquid

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

SKAN Group AG Competitors

Price History & Performance

Summary of share price highs, lows and changes for SKAN Group
Historical stock prices
Current Share Price	CHF 75.80
52 Week High	CHF 77.50
52 Week Low	CHF 70.70
Beta	1.11
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	7.21%

Recent updates

Shareholder Returns

	7VG	DE Life Sciences	DE Market
7D	0.9%	-2.6%	-0.9%
1Y	n/a	-5.8%	14.1%

Return vs Industry: Insufficient data to determine how 7VG performed against the German Life Sciences industry.

Return vs Market: Insufficient data to determine how 7VG performed against the German Market.

Price Volatility

Is 7VG's price volatile compared to industry and market?
7VG volatility
7VG Average Weekly Movement	n/a
Life Sciences Industry Average Movement	7.1%
Market Average Movement	6.5%
10% most volatile stocks in DE Market	12.7%
10% least volatile stocks in DE Market	3.1%

Stable Share Price: 7VG's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine 7VG's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1968	1,500	GL Huber	skan.com/de/home/

SKAN Group AG, together with its subsidiaries, provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally. It operates in two segments, Equipment and Solutions; and Services and Consumables. The company offers accessories, biological indicators, digital ventures, isolators, cleanroom, laminar flow, particle counter, personal protective equipment, safety workbench, transfer systems, and fume cupboard.

SKAN Group AG Fundamentals Summary

How do SKAN Group's earnings and revenue compare to its market cap?
7VG fundamental statistics
Market cap	€1.69b
Earnings (TTM)	€41.61m
Revenue (TTM)	€387.47m

40.6x

P/E Ratio

4.4x

P/S Ratio

Is 7VG overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
7VG income statement (TTM)
Revenue	CHF 361.30m
Cost of Revenue	CHF 100.98m
Gross Profit	CHF 260.32m
Other Expenses	CHF 221.51m
Earnings	CHF 38.80m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Aug 19, 2025

Earnings per share (EPS)	1.73
Gross Margin	72.05%
Net Profit Margin	10.74%
Debt/Equity Ratio	2.7%

How did 7VG perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

23%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/23 16:54
End of Day Share Price	2025/05/23 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

SKAN Group AG is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Volker Bosse	Baader Helvea Equity Research
Leonildo Delgado	Baader Helvea Equity Research
Samuel England	Berenberg

SKAN Group DB:7VG Stock Report